
Sign up to save your podcasts
Or


In this episode, we discuss the prevalence of smoking among people with psychosis, based on recent findings from the PATH study. Dr. Oliver Freudenreich shares insights on how clinicians can prioritize smoking cessation in this population. How can we bridge the health outcome disparities faced by our patients with psychosis?
Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.
 By Psychopharmacology Institute
By Psychopharmacology Institute4.6
268268 ratings
In this episode, we discuss the prevalence of smoking among people with psychosis, based on recent findings from the PATH study. Dr. Oliver Freudenreich shares insights on how clinicians can prioritize smoking cessation in this population. How can we bridge the health outcome disparities faced by our patients with psychosis?
Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.

75 Listeners

149 Listeners

262 Listeners

3,340 Listeners

158 Listeners

565 Listeners

1,347 Listeners

715 Listeners

240 Listeners

566 Listeners

17 Listeners

471 Listeners

725 Listeners

185 Listeners

140 Listeners